CV Sciences Statistics
Total Valuation
CV Sciences has a market cap or net worth of 5.53 million. The enterprise value is 5.38 million.
| Market Cap | 5.53M |
| Enterprise Value | 5.38M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 184.26 million shares outstanding. The number of shares has increased by 10.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 184.26M |
| Shares Change (YoY) | +10.48% |
| Shares Change (QoQ) | +5.71% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.00% |
| Float | 184.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 4.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.12 |
| EV / Sales | 0.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.10 |
| Quick Ratio | 0.23 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.04 |
Financial Efficiency
Return on equity (ROE) is -89.49% and return on invested capital (ROIC) is -26.19%.
| Return on Equity (ROE) | -89.49% |
| Return on Assets (ROA) | -9.77% |
| Return on Capital (ROIC) | -26.19% |
| Revenue Per Employee | 363,302 |
| Profits Per Employee | -59,000 |
| Employee Count | 43 |
| Asset Turnover | 1.73 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.84% in the last 52 weeks. The beta is 0.66, so CV Sciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -20.84% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 38.01 |
| Average Volume (20 Days) | 380,294 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, CV Sciences had revenue of 15.62 million and -2.54 million in losses. Loss per share was -0.02.
| Revenue | 15.62M |
| Gross Profit | 7.23M |
| Operating Income | -1.41M |
| Pretax Income | -2.54M |
| Net Income | -2.54M |
| EBITDA | -1.13M |
| EBIT | -1.41M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 979,000 in cash and 835,000 in debt, giving a net cash position of 144,000 or 0.00 per share.
| Cash & Cash Equivalents | 979,000 |
| Total Debt | 835,000 |
| Net Cash | 144,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.19M |
| Book Value Per Share | 0.01 |
| Working Capital | 605,000 |
Cash Flow
| Operating Cash Flow | -811,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.30%, with operating and profit margins of -9.02% and -16.24%.
| Gross Margin | 46.30% |
| Operating Margin | -9.02% |
| Pretax Margin | -16.26% |
| Profit Margin | -16.24% |
| EBITDA Margin | -7.23% |
| EBIT Margin | -9.02% |
| FCF Margin | n/a |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.48% |
| Shareholder Yield | -10.48% |
| Earnings Yield | -50.60% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CV Sciences has an Altman Z-Score of -12.27. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.27 |
| Piotroski F-Score | n/a |